Business Information
The group's principal activities are preservation of human tissues for cardiovascular, vascular and orthopaedic transplant applications. The group operates in two segments namely human tissue preservation services and implantable medical devices. Human tissue preservation services include preservation of cardiovascular, vascular and orthopaedic human tissue. Implantable medical devices segment includes product sales of bioglue surgical adhesive and bioprosthetic devices, including stentless porcine heart valves, synergraft treated porcine heart valves and synergraft treated bovine vascular grafts. The group's human tissue cryopreservation services are marketed in North America, Europe, the Middle East, Canada, South America, Australia, and Asia.
|
|
Name |
Title
|
Email
|
| Steven Anderson | Chmn., CEO, Pres. | Available | | Amy Horton | Chief Accounting Officer | Available | | Scott Capps | Corporate Officers | Available | | Albert Heacox | Sr. VP - Research, Development | Available | | David Fronk | VP - Regulatory Affairs, Quality Assurance | Available
|
|
|
Year |
Sales |
Net Income |
| 2006 | 81,311 | 365 | | 2005 | 69,282 | (19,535) | | 2004 | 62,384 | (18,749)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
